Author Archives: Stefan Avall
Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study
04/02/2024
(Vancouver | April 2, 2024) — Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today the successful completion of enrollment in the paroxysmal cohort of the pivotal PULSAR IDE (Investigational Device Exemption) study. This achievement marks a […]
Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
05/31/2023
(Vancouver | May 31, 2023) Kardium Inc., a private medical device company that has developed the Globe System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first US patients have been successfully treated in the PULSAR clinical study. The PULSAR study will enroll over 400 patients for […]